
Epigenomic Disruption in Brain Cells Drives Alzheimer’s Cognitive Decline
A large-scale study reveals that Alzheimer's disease involves fundamental breakdowns in epigenomic control within brain cells, leading to gene expression dysregulation and cognitive decline, suggesting new treatment avenues targeting genome stability.

